Hu T - Search Results

1

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer.

Long M, You C, Song Q, Hu LXJ, Guo Z, Yao Q, Hou W, Sun W, Liang B, Zhou XH, Liu Y, Hu T. Long M, et al. Among authors: hu t, hu lxj. Life (Basel). 2022 Dec 27;13(1):74. doi: 10.3390/life13010074. Life (Basel). 2022. PMID: 36676023 Free PMC article.

2

The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later.

Hu T, Long M, Yuan D, Zhu Z, Huang Y, Huang S. Hu T, et al. Sci China Life Sci. 2013 Mar;56(3):254-61. doi: 10.1007/s11427-013-4452-x. Epub 2013 Mar 23. Sci China Life Sci. 2013. PMID: 23526392 Free article. Review.

3

Tripartite genome of all species.

Long M, Hu T. Long M, et al. Among authors: hu t. F1000Res. 2016 Feb 19;5:195. doi: 10.12688/f1000research.8008.1. eCollection 2016. F1000Res. 2016. PMID: 27366319 Free PMC article.

4

A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer.

Long M, Hou W, Liu Y, Hu T. Long M, et al. Among authors: hu t. Curr Oncol. 2021 Feb 17;28(1):928-939. doi: 10.3390/curroncol28010091. Curr Oncol. 2021. PMID: 33617509 Free PMC article.

5

Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores.

Hu T, Chen Y, Liu Y, Zhang D, Pan J, Long M. Hu T, et al. BMC Med Res Methodol. 2021 May 22;21(1):108. doi: 10.1186/s12874-021-01297-8. BMC Med Res Methodol. 2021. PMID: 34022815 Free PMC article.

6

A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes.

Hu T, Zhao G, Liu Y, Long M. Hu T, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027900. doi: 10.1177/15330338211027900. Technol Cancer Res Treat. 2021. PMID: 34159849 Free PMC article.

7

Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database.

Hu T, Wu J, Long M, Zhou X, Wang S. Hu T, et al. Gland Surg. 2022 Jan;11(1):236-244. doi: 10.21037/gs-21-919. Gland Surg. 2022. PMID: 35242685 Free PMC article.

8

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy.

Hu T, Liu Y, Wu J, Hu XL, Zhao G, Liang B, Wang S, Long M. Hu T, et al. Among authors: hu xl. J Clin Med. 2022 Mar 14;11(6):1607. doi: 10.3390/jcm11061607. J Clin Med. 2022. PMID: 35329934 Free PMC article.

9

Intraparenchymal breast leiomyoma and atypical leiomyoma.

Long M, Hu XL, Zhao G, Liu Y, Hu T. Long M, et al. Among authors: hu t, hu xl. BMC Womens Health. 2022 Apr 14;22(1):119. doi: 10.1186/s12905-022-01700-6. BMC Womens Health. 2022. PMID: 35421983 Free PMC article.

10

The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database.

Wu J, Liu H, Hu T, Long M, Zhou X, Wang S. Wu J, et al. Among authors: hu t. Ann Transl Med. 2022 Mar;10(6):365. doi: 10.21037/atm-22-918. Ann Transl Med. 2022. PMID: 35433996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,499 results

Search Page